{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:57:21Z","timestamp":1791212241131,"version":"4.1.0"},"reference-count":84,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/tp.0000000000000903","type":"journal-article","created":{"date-parts":[[2015,9,10]],"date-time":"2015-09-10T22:05:42Z","timestamp":1441922742000},"page":"497-505","source":"Crossref","is-referenced-by-count":35,"title":["The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder"],"prefix":"10.1097","volume":"100","author":[{"given":"Michael E.","family":"Seifert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Hruska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-13-20210129","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(14)60384-6","article-title":"Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure.","volume":"383","author":"Ortiz","year":"2014","journal-title":"Lancet"},{"key":"R4-13-20210129","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"R5-13-20210129","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.1999.00773.x","article-title":"Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency.","volume":"56","author":"Culleton","year":"1999","journal-title":"Kidney Int"},{"key":"R6-13-20210129","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1399-3046.2006.00565.x","article-title":"Left ventricular hypertrophy in pediatric kidney transplant recipients: long-term follow-up study.","volume":"10","author":"Bullington","year":"2006","journal-title":"Pediatr Transplant"},{"key":"R7-13-20210129","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2004030203","article-title":"Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare Population, 1998 to 1999.","volume":"16","author":"Foley","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R8-13-20210129","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ahj.2013.05.008","article-title":"Risk for recurrent coronary heart disease and all-cause mortality among individuals with chronic kidney disease compared with diabetes mellitus, metabolic syndrome, and cigarette smokers.","volume":"166","author":"Baber","year":"2013","journal-title":"Am Heart J"},{"key":"R9-13-20210129","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"R10-13-20210129","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ki.2013.150","article-title":"Plasma FGF23 levels increase rapidly after acute kidney injury.","volume":"84","author":"Christov","year":"2013","journal-title":"Kidney Int"},{"key":"R11-13-20210129","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1681\/ASN.2013080818","article-title":"CKD-induced winglessintegration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder.","volume":"25","author":"Fang","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R12-13-20210129","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.","volume":"22","author":"Wolf","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R13-13-20210129","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000362251","article-title":"Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease.","volume":"39","author":"Seifert","year":"2014","journal-title":"Am J Nephrol"},{"key":"R14-13-20210129","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000353569","article-title":"Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease.","volume":"38","author":"Seifert","year":"2013","journal-title":"Am J Nephrol"},{"key":"R15-13-20210129","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease.","volume":"22","author":"Hu","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R17-13-20210129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.","volume":"26","author":"Consortium","year":"2000","journal-title":"Nat Genet"},{"key":"R18-13-20210129","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"R19-13-20210129","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2215\/CJN.05840513","article-title":"Disordered FGF23 and mineral metabolism in children with CKD.","volume":"9","author":"Portale","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R20-13-20210129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1681\/ASN.2012070713","article-title":"Mineral metabolites and CKD progression in African Americans.","volume":"24","author":"Scialla","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R21-13-20210129","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","article-title":"Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.","volume":"78","author":"Hasegawa","year":"2010","journal-title":"Kidney Int"},{"key":"R22-13-20210129","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ndt\/gfs411","article-title":"Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.","volume":"28","author":"Wan","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R23-13-20210129","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","article-title":"Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease.","volume":"45","author":"Pereira","year":"2009","journal-title":"Bone"},{"key":"R24-13-20210129","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jbmr.516","article-title":"Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease.","volume":"27","author":"Stubbs","year":"2012","journal-title":"J Bone Miner Res"},{"key":"R25-13-20210129","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2215\/CJN.10941013","article-title":"The use of fibroblast growth factor 23 testing in patients with kidney disease.","volume":"9","author":"Smith","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R26-13-20210129","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00467-013-2547-z","article-title":"FGF23 and mineral metabolism in the early post-renal transplantation period.","volume":"28","author":"Wesseling-Perry","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R27-13-20210129","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2215\/CJN.07860814","article-title":"A longitudinal study of inflammation, CKD-mineral bone disorder, and carotid atherosclerosis after renal transplantation.","volume":"10","author":"Yilmaz","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R28-13-20210129","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R29-13-20210129","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.2215\/CJN.01880213","article-title":"Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation.","volume":"8","author":"Baia","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R30-13-20210129","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2013050465","article-title":"Fibroblast growth factor-23 and cardiovascular events in CKD.","volume":"25","author":"Scialla","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R31-13-20210129","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"FIbroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"R32-13-20210129","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy.","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"R33-13-20210129","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.2012070719","article-title":"Cardiovascular effects of sevelamer in stage 3 CKD.","volume":"24","author":"Chue","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R34-13-20210129","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/ndt\/gfq419","article-title":"Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease.","volume":"26","author":"Isakova","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R35-13-20210129","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/emmm.201303716","article-title":"FGF23 regulates renal sodium handling and blood pressure.","volume":"6","author":"Andrukhova","year":"2014","journal-title":"EMBO Mol Med"},{"key":"R36-13-20210129","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.ajkd.2014.07.022","article-title":"Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.","volume":"65","author":"Humalda","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R37-13-20210129","first-page":"1486","article-title":"Post-transplant hypophosphatemia: tertiary hyper-phosphatoninism Kidney Int.","volume":"70","author":"Bhan","year":"2006","journal-title":""},{"key":"R38-13-20210129","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1093\/ndt\/gfs409","article-title":"Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.","volume":"27","author":"Sanchez Fructuoso","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R39-13-20210129","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2009-1576","article-title":"The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease.","volume":"95","author":"Bacchetta","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R40-13-20210129","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/TP.0b013e3181e117b4","article-title":"Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene.","volume":"90","author":"Han","year":"2010","journal-title":"Transplantation"},{"issue":"Suppl 16","key":"R41-13-20210129","first-page":"S136","article-title":"Klotho and kidney disease.","volume":"23","author":"Hu","year":"2010","journal-title":"J Nephrol"},{"key":"R42-13-20210129","doi-asserted-by":"crossref","first-page":"19796","DOI":"10.1073\/pnas.0709805104","article-title":"Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17.","volume":"104","author":"Chen","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R43-13-20210129","doi-asserted-by":"crossref","first-page":"e86301","DOI":"10.1371\/journal.pone.0086301","article-title":"Reduced renal -Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism.","volume":"9","author":"Sakan","year":"2014","journal-title":"PLoS One"},{"key":"R44-13-20210129","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/ki.2010.328","article-title":"Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective.","volume":"78","author":"Hu","year":"2010","journal-title":"Kidney Int"},{"key":"R45-13-20210129","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/ndt\/gfs050","article-title":"FGF23 and PTHdouble agents at the heart of CKD.","volume":"27","author":"Silver","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R46-13-20210129","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1681\/ASN.2004100835","article-title":"Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome.","volume":"16","author":"Davies","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R47-13-20210129","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1681\/ASN.2007070760","article-title":"The mechanism of phosphorus as a cardiovascular risk factor in CKD.","volume":"19","author":"Mathew","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R48-13-20210129","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ki.2008.130","article-title":"Hyperphosphatemia of chronic kidney disease.","volume":"74","author":"Hruska","year":"2008","journal-title":"Kidney Int"},{"key":"R49-13-20210129","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1074\/jbc.273.9.5253","article-title":"RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate.","volume":"273","author":"Moallem","year":"1998","journal-title":"J Biol Chem"},{"key":"R50-13-20210129","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"R51-13-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1399-3046.2010.01405.x","article-title":"Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation.","volume":"15","author":"Seeherunvong","year":"2011","journal-title":"Pediatr Transplant"},{"key":"R52-13-20210129","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2215\/CJN.06200614","article-title":"Mineral metabolism in European children living with a renal transplant: a European society for paediatric nephrologyeuropean renal association-European dialysis and transplant association registry study.","volume":"10","author":"Bonthuis","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R53-13-20210129","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/ajt.12652","article-title":"Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States.","volume":"14","author":"Sukumaran Nair","year":"2014","journal-title":"Am J Transplant"},{"key":"R54-13-20210129","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.1600-6143.2011.03590.x","article-title":"Rapamycin-induced hypophosphatemia and insulin resistance are associated with mTORC2 activation and Klotho expression.","volume":"11","author":"Tataranni","year":"2011","journal-title":"Am J Transplant"},{"key":"R55-13-20210129","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.2215\/CJN.07851109","article-title":"Association between clinical risk factors and progression of chronic kidney disease in children.","volume":"5","author":"Staples","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Supplement 1","key":"R56-13-20210129","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.2215\/CJN.05910809","article-title":"Calcium metabolism in health and disease.","volume":"5","author":"Peacock","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R57-13-20210129","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1399-3046.2012.01702.x","article-title":"Fibroblast growth factor 23 and calcium phosphate homeostasis after pediatric renal transplantation.","volume":"16","author":"van Husen","year":"2012","journal-title":"Pediatr Transplant"},{"key":"R58-13-20210129","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ki.2010.107","article-title":"Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease.","volume":"78","author":"van Husen","year":"2010","journal-title":"Kidney Int"},{"key":"R59-13-20210129","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","article-title":"Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease.","volume":"83","author":"Hill","year":"2013","journal-title":"Kidney Int"},{"key":"R60-13-20210129","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2215\/CJN.02680310","article-title":"Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23Klotho system.","volume":"5","author":"Prie","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R61-13-20210129","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1172\/JCI114931","article-title":"Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo.","volume":"86","author":"Naveh-Many","year":"1990","journal-title":"J Clin Invest"},{"key":"R62-13-20210129","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00467-010-1452-y","article-title":"Vitamin D insufficiency: implications for the immune system.","volume":"25","author":"Baeke","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R63-13-20210129","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.1432-2277.2005.00187.x","article-title":"Prevention of chronic allograft nephropathy with vitamin D.","volume":"18","author":"Hullett","year":"2005","journal-title":"Transpl Int"},{"key":"R64-13-20210129","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/ki.2014.215","article-title":"Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription.","volume":"86","author":"Meir","year":"2014","journal-title":"Kidney Int"},{"key":"R65-13-20210129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.semnephrol.2012.12.017","article-title":"Chronic kidney disease: mineral and bone disorder in children.","volume":"33","author":"Wesseling-Perry","year":"2013","journal-title":"Semin Nephrol"},{"key":"R66-13-20210129","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1111\/ajt.12911","article-title":"A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism.","volume":"14","author":"Evenepoel","year":"2014","journal-title":"Am J Transplant"},{"key":"R67-13-20210129","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrneph.2013.198","article-title":"Evaluating bone quality in patients with chronic kidney disease.","volume":"9","author":"Malluche","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"R68-13-20210129","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2003.12.004","article-title":"Osteoporosis in chronic kidney disease.","volume":"43","author":"Cunningham","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R69-13-20210129","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","article-title":"Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.","volume":"56","author":"Rix","year":"1999","journal-title":"Kidney Int"},{"key":"R70-13-20210129","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone.","volume":"36","author":"Coco","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"R71-13-20210129","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jacc.2009.06.017","article-title":"Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study).","volume":"54","author":"Ix","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R72-13-20210129","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.RES.0000141775.67189.98","article-title":"Pathophysiology of vascular calcification in chronic kidney disease.","volume":"95","author":"Moe","year":"2004","journal-title":"Circ Res"},{"key":"R73-13-20210129","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/CIRCULATIONAHA.106.674143","article-title":"Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA).","volume":"115","author":"Kronmal","year":"2007","journal-title":"Circulation"},{"key":"R74-13-20210129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/path.4121","article-title":"Wnt signalling in kidney diseases: dual roles in renal injury and repair.","volume":"229","author":"Kawakami","year":"2013","journal-title":"J Pathol"},{"key":"R75-13-20210129","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling.","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat Med"},{"key":"R76-13-20210129","first-page":"95A","article-title":"Chronic Kidney Disease (CKD) Stimulates Activin and Endothelial to Mesenchymal Transition (EnMT), which Causes Vascular Calcification and is Inhibited by an Activin Ligand Trap Abstract.","volume":"25","author":"Hruska","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R77-13-20210129","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy.","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R78-13-20210129","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ndt\/gfv081","article-title":"Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.","volume":"30","author":"Morena","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"R79-13-20210129","doi-asserted-by":"crossref","first-page":"e56695","DOI":"10.1371\/journal.pone.0056695","article-title":"A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease.","volume":"8","author":"Kitagawa","year":"2013","journal-title":"PLoS One"},{"key":"R80-13-20210129","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2215\/CJN.05940611","article-title":"Early skeletal and biochemical alterations in pediatric chronic kidney disease.","volume":"7","author":"Wesseling-Perry","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R81-13-20210129","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/ATVBAHA.113.300647","article-title":"Dkk1 and MSX2-Wnt7b signaling reciprocally regulate the endothelial-mesenchymal transition in aortic endothelial cells.","volume":"33","author":"Cheng","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R82-13-20210129","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.yjmcc.2009.07.022","article-title":"Renal studies provide an insight into cardiac extracellular matrix remodeling during health and disease.","volume":"48","author":"Hertig","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"R83-13-20210129","first-page":"865A","article-title":"Elevated fibroblast growth factor 23 levels are associated with chronic rejection and declining kidney transplant function.","volume":"24","author":"Seifert","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R84-13-20210129","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2215\/CJN.07670712","article-title":"The relation between renal function and serum sclerostin in adult patients with CKD.","volume":"8","author":"Pelletier","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R85-13-20210129","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2215\/CJN.07870713","article-title":"Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.","volume":"9","author":"Seiler","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R86-13-20210129","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1111\/j.1600-6143.2009.02762.x","article-title":"Wnt pathway regulation in chronic renal allograft damage.","volume":"9","author":"von Toerne","year":"2009","journal-title":"Am J Transplant"},{"key":"R87-13-20210129","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1681\/ASN.2012010012","article-title":"Inhibition of WISE preserves renal allograft function.","volume":"24","author":"Qian","year":"2013","journal-title":"J Am Soc Nephrol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000000903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:21:03Z","timestamp":1620976863000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201603000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000000903","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}